Loading...

cbdMD, Inc.

YCBD-PA•AMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$4.18
$3.53(546.36%)

cbdMD, Inc. (YCBD-PA) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.2/100

Key Financials

Market Cap456.3K
P/E Ratio-1.64
EPS (TTM)$-0.50
ROE-0.96%
Fundamental Analysis

AI Price Forecasts

1 Week$0.80
1 Month$0.76
3 Months$1.86
1 Year Target$0.44

YCBD-PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of cbdMD, Inc. (YCBD-PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.78, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.44.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.64 and a market capitalization of 456.3K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
10.87%
5-Day Change
18.60%
1-Month Change
15.04%
3-Month Change
75.86%
6-Month Change
131.82%
Year-to-Date (YTD) Change
85.45%
1-Year Change
112.62%
3-Year Change
-70.00%
5-Year Change
-75.08%
All-Time (Max) Change
-83.37%

Contact Information

https://www.cbdmd.com
704 445 3060
8845 Red Oak Boulevard, Charlotte, NC, 28217

Company Facts

42 Employees
IPO DateOct 21, 2019
CountryUS
Actively Trading

Frequently Asked Questions

;